Jose L Mondaza-Hernandez

10PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPatient safetySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 02, 2026
Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis.

|Mar 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma.

Javier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge

|Jan 15, 2026
Validation of a Seven-Gene Predictive SIGNature for the Efficacy of Immuno-Oncology PD-1 Inhibitors in Patients with Sarcoma.

David S Moura, Jesus Lopez-Marti, Hussein Tawbi

|Nov 06, 2024
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma.

José L Mondaza-Hernandez, Nadia Hindi, Antonio Fernandez-Serra

|Sep 16, 2024
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial.

David S Moura, Jesus M Lopez-Marti, Iva Benesova

|Jan 11, 2024
Delays in diagnosis and surgery of sarcoma patients during the COVID-19 outbreak in Spain.

Jaime Carrillo-García, Serena Lacerenza, Nadia Hindi

Pageof 2

Frequent Collaborators

9 joint publications

Javier Martin-Broto

6 joint publications

David S Moura

4 joint publications

Nadia Hindi

2 joint publications

Antonio Gutierrez